Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.59T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  ZBH

Zimmer Biomet Holdings Inc

ZBH
55 / 100
S&P500
$126.88arrow_drop_down-1.78%-$2.30

Performance History

Stocklytics logo
Key Stats
Open$128.63
Prev. Close$128.53
EPS4.88
Dividend$0.96
Next Earnings DateJul 29, 2024
Dividend Yield %0.74%
Market Cap$26.99B
PE Ratio26.47
LOWHIGH
Day Range128.08
129.50
52 Week Range102.00
149.25
Ratios
P/B Ratio2.16
Revenue$1.94B
Operating M. %22.66%
Earnings$1.02B
Earnings Growth %251.65%
EBITDA Margin %100.00%
ROE %8.36%
EPS4.88

Score Breakdown

55vs 53. Market Avg.

All Score 55 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

ZBHMARKET
Value3239
Quality5640
Ownership3719
Growth5346
Dividends1037
warning

Zimmer Biomet Holdings Inc's Price growth average in the last 3 years of -5.97% is modest compared to market average of 6.66%. This indicates ZBH could be a bad value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$769.53
24H (%)arrow_drop_down-0.01%
24H ($)-$0.10
MARKET CAP$731.18B
PRICE$527.23
24H (%)arrow_drop_up0.14%
24H ($)$0.73
MARKET CAP$487.65B
PRICE$161.84
24H (%)arrow_drop_up0.86%
24H ($)$1.39
MARKET CAP$389.83B
PRICE$129.45
24H (%)arrow_drop_up0.14%
24H ($)$0.19
MARKET CAP$328.02B

About Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Bryan C. Hanson
Headquarters
Warsaw
Employees
18000
Exchange
NYSE
add Zimmer Biomet Holdings Inc to watchlist

Keep an eye on Zimmer Biomet Holdings Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is Zimmer Biomet Holdings Inc's (ZBH) price per share?

The current price per share for Zimmer Biomet Holdings Inc (ZBH) is $129.18. The stock has seen a price change of $0.64 recently, indicating a 0.5% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for Zimmer Biomet Holdings Inc (ZBH)?

For Zimmer Biomet Holdings Inc (ZBH), the 52-week high is $149.25, which is 15.54% from the current price. The 52-week low is $102, the current price is 26.65% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is Zimmer Biomet Holdings Inc (ZBH) a growth stock?

Zimmer Biomet Holdings Inc (ZBH) has shown an average price growth of -5.97% over the past three years. It has received a score of 43 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zimmer Biomet Holdings Inc as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is Zimmer Biomet Holdings Inc (ZBH) stock price performance year to date (YTD)?

As of the latest data, Zimmer Biomet Holdings Inc (ZBH) has a year-to-date price change of 6.41%. Over the past month, the stock has experienced a price change of 5.95%. Over the last three months, the change has been 13.48%. Looking at a longer horizon, the five-year price change stands at 4.26%.

question_mark
Is Zimmer Biomet Holdings Inc (ZBH) a profitable company?

Zimmer Biomet Holdings Inc (ZBH) has a net income of $1.02B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 64.76% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 22.66% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.94B, although specific revenue growth data is currently not available. The gross profit is $1.26B. Operating income is noted at $1.26B. Furthermore, the EBITDA is $2.43B.

question_mark
What is the market capitalization of Zimmer Biomet Holdings Inc (ZBH)?

Zimmer Biomet Holdings Inc (ZBH) has a market capitalization of $27B. The average daily trading volume is 1.73M, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.